What is Clenbuterol?
Clenbuterol is a bronchodilator used in asthma medicine worldwide for the treatment of allergic respiratory disease in horses. A common trade name is Ventipulmin, and it can be used both orally and intravenously. Clenbuterol is also a non-steroidal anabolic and metabolism accelerator, through a mechanism not well understood, which is why it is used illegally by athletes to build muscle. Its ability, however, to induce weight gain and ensure a greater proportion of muscle makes its illegal use in livestock popular. Clenbuterol accumulates in the human body through ingestion. It is heat stable only decomposing at temperatures over 172 degrees Celsius. Thus, cooking cannot easily eliminate toxicity. Long-term consumption can lead to malignant tumours but it also poses dangers to patients who have high blood pressure or diabetes. Patients and those with excess intake often share similar symptoms including palpitations, nausea, vomiting, dizziness, chest tightness, anxiety, shaking, weakness, and instability.
Further information
MoniQA has developed a factsheet with information about Clenbuterol, the case in China, occurances in Europe and the activtiies of the MoniQA in this field. This factsheet is available for download below.
Clenbuterol is a bronchodilator used in asthma medicine worldwide for the treatment of allergic respiratory disease in horses. A common trade name is Ventipulmin, and it can be used both orally and intravenously. Clenbuterol is also a non-steroidal anabolic and metabolism accelerator, through a mechanism not well understood, which is why it is used illegally by athletes to build muscle. Its ability, however, to induce weight gain and ensure a greater proportion of muscle makes its illegal use in livestock popular. Clenbuterol accumulates in the human body through ingestion. It is heat stable only decomposing at temperatures over 172 degrees Celsius. Thus, cooking cannot easily eliminate toxicity. Long-term consumption can lead to malignant tumours but it also poses dangers to patients who have high blood pressure or diabetes. Patients and those with excess intake often share similar symptoms including palpitations, nausea, vomiting, dizziness, chest tightness, anxiety, shaking, weakness, and instability.
Further information
MoniQA has developed a factsheet with information about Clenbuterol, the case in China, occurances in Europe and the activtiies of the MoniQA in this field. This factsheet is available for download below.
Printer-friendly version